Orai 1 inhibitors (Incozen Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameOrai 1 inhibitors (Incozen Therapeutics)
Drug Alias Namecalcium release-activated calcium channel inhibitor (Incozen Therapeutics)RP-4009RP-3042RP-3035
ClassificationSmall molecules
Mechanisms of ActionCalcium release-activated calcium channel protein 1 blockers
TargetsCalcium release-activated calcium channel protein 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerlandIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIncozen Therapeutics Pvt Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIncozen Therapeutics Pvt LtdRhizen Pharmaceuticals Sa
Active IndicationsN/A
Inactive IndicationsCarcinoma, Non-Small-Cell Lung

Other Information

ATC CodeN/A
Related LinksN/A